Life News Hub

Hims & Hers: FDA Ruling May Close GLP-1 Drug 'Loophole', It Was Fun While It Lasted (HIMS)

By Edmund Ingham
From Seeking Alpha

Hims & Hers: FDA Ruling May Close GLP-1 Drug 'Loophole', It Was Fun While It Lasted (HIMS)

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth. Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.

Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston BioHealth. The group is for both novice and experienced biotech investors. It provides catalysts to look out for and buy and sell ratings. It also provides product sales and forecasts for all the Big Pharmas, forecasting, integrated financial statements, discounted cash flow analysis and market by market analysis.

Previous articleNext article

POPULAR CATEGORY

entertainment

11123

discovery

4960

multipurpose

11710

athletics

11873